Vanda Pharmaceuticals (VNDA) sNDA for Fanapt Approved by U.S. FDA for Schizophrenia

Go back to Vanda Pharmaceuticals (VNDA) sNDA for Fanapt Approved by U.S. FDA for Schizophrenia
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) Delayed: 9.79 +0.04 (0.41%)
Previous Close $9.75    52 Week High $18.00 
Open $9.77    52 Week Low $6.91 
Day High $10.07    P/E N/A 
Day Low $9.74    EPS $-0.67 
Volume 672,793